IVF, Peripheral Neuropathy, and the Mitochondrial Foundation: Why NAD Matters
- Jun 16
- 8 min read
Peripheral neuropathy and reduced reproductive function share one underlying foundation: mitochondrial competence, the cellular machinery that turns substrate into usable energy. The same MitoNAD plus foundational support we use at our Mankato clinic for nerve repair is also relevant to the pre-cycle window for patients exploring IVF, in coordination with the reproductive endocrinologist.
Important disclaimer. This article is general patient education from a Doctor of Chiropractic. It is not a substitute for evaluation by a reproductive endocrinologist or your IVF team. The mitochondrial and nutritional considerations discussed here are foundational support, not fertility treatment. Any decision about IVF medications, protocols, or supplementation in the pre-cycle window must be made with the reproductive endocrinologist managing your care. If you are pursuing IVF, the reproductive endocrinologist's plan takes precedence.
Summary
Two chronic concerns we see at our Mankato chiropractic clinic share a common foundation: peripheral neuropathy and reduced reproductive function. Both depend on mitochondrial competence, the cellular machinery that converts substrate into the energy peripheral nerves need to repair themselves and that oocytes need to fertilize, cleave, and implant. Both are sensitive to the availability of NAD plus, methylation cofactors, vitamin D, and key minerals. And both, in the right patients, respond to foundational metabolic support that addresses the underlying mitochondrial picture.
This article is patient education on why the same MitoNAD plus foundational approach we use at our Mankato clinic for peripheral neuropathy is also relevant to patients exploring IVF, and why coordination with the reproductive endocrinologist comes first.
Why mitochondria matter for nerves and for maturing follicles
The mature human oocyte is the most mitochondria-dense cell in the human body, containing roughly 100,000 mitochondria, about 10,000 times the count in a typical somatic cell. Peripheral nerves are not as dense as oocytes, but their long axons and constant signaling load make them disproportionately mitochondria-dependent in a different way: the energy demand for maintenance and repair runs continuously, year after year.
The shared theme: when mitochondrial output declines, both tissues feel it. Peripheral neuropathy patients in our Mankato practice often have markers of mitochondrial insufficiency: low NAD plus pools, depleted methylation cofactors, low magnesium. So do many patients in our practice exploring assisted reproduction. The foundation that supports peripheral nerve repair is the same foundation that supports oocyte energetics.
Bottom line. Mitochondrial competence is a shared foundation underneath both peripheral neuropathy and oocyte function. Restoring the foundation does not treat infertility or cure neuropathy. It supports the cellular machinery both tissues depend on.
Why follicle quality is downstream of mitochondrial function
Reproductive endocrinology has long used the phrase follicle quality as a shorthand for oocyte fitness. The phrase captures something real, but it does so at a level of abstraction that makes intervention difficult. Patients are told their follicle quality is the variable. No protocol is offered to change follicle quality. The phrase becomes a stopping point.
The biology is more specific. The mature oocyte's developmental competence, its ability to support fertilization, normal cleavage, and progression to blastocyst, depends substantially on the energetic state of the cell at the moment of retrieval and immediately after fertilization. The energetic state is a function of mitochondrial number, mitochondrial membrane integrity, and the availability of NAD plus and other cofactors required to convert substrate into ATP.
These variables are modifiable. They are not modifiable in the days before retrieval. They are modifiable in the 60 to 120 days of oocyte recruitment and final maturation that precedes ovulation. This intervention window is determined entirely by reproductive biology and must be coordinated with the reproductive endocrinologist managing the cycle.
Bottom line. Mitochondrial competence and NAD plus availability are the underlying biological variables behind much of what gets labeled follicle quality. The 60 to 120 day window before retrieval is when foundational metabolic support is biologically relevant, and any pre-cycle changes belong in conversation with the reproductive endocrinologist.
What the published evidence supports for ovarian and IVF foundational support
The reproductive medicine literature on supplementation is more nuanced than either the nothing works position or the stack everything position. Below is a brief, honest summary of the major nutritional and supplementation areas with reasonable published support relevant to ovarian function and IVF outcomes. None of these is a substitute for reproductive endocrinology care. All of them are foundational, not curative, and all of them should be discussed with the IVF team before adoption.
Coenzyme Q10 (ubiquinol)
Randomized data in women with diminished ovarian reserve suggests improved ovarian response with pre-cycle CoQ10 supplementation over a 60 to 90 day window. The ubiquinol form is generally preferred for older patients. Specific dose ranges vary across the literature. The appropriate dose for any individual patient depends on labs, age, and clinical picture, and the decision belongs to the IVF team.
NAD plus precursor support (nicotinamide riboside and NMN)
Animal data and emerging human data suggest NAD plus precursor supplementation may restore ovarian NAD plus pools and improve oocyte quality markers in models of reproductive aging. The human IVF outcome data is preliminary. The mechanistic case is strong. Clinical adoption by reproductive endocrinologists is increasing but uneven. Whether this is appropriate for any individual patient is a reproductive endocrinology decision.
Omega-3 fatty acids
EPA and DHA supplementation has reasonable evidence for improved follicular fluid composition and improved IVF outcomes. The mechanism appears to involve both membrane composition and inflammation modulation.
Methylation support (B12, methylfolate, B6, choline)
Methylation status affects DNA methylation patterns established during oogenesis and early embryogenesis. Folic acid supplementation has been standard pre-conception care for decades. Methylfolate is the form preferred for patients with MTHFR polymorphisms, where folic acid conversion is impaired.
Vitamin D
Vitamin D sufficiency has reasonable evidence for improved IVF outcomes, particularly in patients deficient at baseline. The mechanism is multifactorial.
What does not have strong evidence
The reproductive supplement market is large and saturated. Many products marketed as fertility support have no controlled-trial evidence. Specific examples we discourage on patient education grounds include high-dose DHEA without clinical indication and proprietary blends with undisclosed dosing.
Bottom line. A short list of nutritional and supplementation areas has reasonable published support for foundational support during the IVF window: CoQ10 (ubiquinol), NAD plus precursors, EPA and DHA omega-3s, methylation support, and vitamin D. The decisions about whether, when, and in what combination to use them belong to the reproductive endocrinology team, not to a chiropractor and not to a blog post.
How patients in Mankato approach this with us, alongside their IVF team
Stenzel Chiropractic Clinic in Mankato is not a fertility clinic. We do not diagnose infertility. We do not prescribe IVF medications. We do not replace the reproductive endocrinologist.
What we offer Mankato-area patients exploring assisted reproduction is foundational metabolic support, the same MitoNAD plus foundational architecture we use for peripheral neuropathy, delivered in coordination with the IVF team.
That looks like:
Patient comes in for a free fifteen-minute consult, often with their prior reproductive endocrinology labs and protocol summary
We review the labs in the context of mitochondrial and methylation foundations
We explain what foundational nutritional support could look like in the 60 to 120 day pre-cycle window
The patient brings that information back to the reproductive endocrinologist
Where the reproductive endocrinologist agrees, we provide the foundational support alongside the IVF team's protocol
Where the reproductive endocrinologist disagrees, the reproductive endocrinologist's plan takes precedence
The foundational support layer does not bypass IVF care. It runs underneath it, in coordination, with the IVF team's awareness.
What this article is not
This article is not a fertility treatment claim. We do not treat infertility.
This article is not a critique of reproductive endocrinology. The IVF teams in southern Minnesota and the Twin Cities are excellent.
This article is not a recommendation to take any specific supplement in any specific dose. Specific decisions belong to the reproductive endocrinologist.
This article is not a substitute for an in-person evaluation. The foundational picture for any patient requires labs and clinical history.
Bottom line. The MitoNAD plus foundational approach is a metabolic support framework, not a fertility treatment. It is appropriate to discuss with the IVF team. It is not appropriate to use as a substitute for reproductive endocrinology care.
Schedule a free foundational consult in Mankato
If you are exploring IVF or already in a cycle, the first call is to your reproductive endocrinologist. If you would like a foundational metabolic perspective to bring to that conversation, a free fifteen-minute Mankato consult walks through your prior labs, the foundational picture, and what foundational support could look like alongside the IVF team's plan.
The same consult is appropriate for Mankato patients exploring the MitoNAD plus foundation for peripheral neuropathy, mitochondrial health, or other foundational metabolic concerns.
Book now at stenzelchiropractic.janeapp.com. Learn more about our MitoNAD plus approach at stenzelchiropractic.com/mito-nad and our peripheral neuropathy program at stenzelchiropractic.com/neuropathy. Locations: Mankato, MN and Mapleton, MN (313 Main St NE).
Frequently Asked Questions
Does NAD+ help with fertility or IVF outcomes?
NAD plus availability is a foundational variable in mitochondrial function, and the mature oocyte is the most mitochondria-dense cell in the human body. Animal data and emerging human data suggest NAD plus precursor supplementation may support ovarian NAD plus pools and oocyte quality markers in models of reproductive aging. Human IVF outcome data is preliminary. Whether NAD plus precursor support is appropriate for any individual patient is a decision for the reproductive endocrinologist managing the cycle, not for a chiropractor or a blog post.
When should I start a foundational metabolic protocol before IVF?
The biologically relevant window is 60 to 120 days before retrieval, which corresponds to the duration of oocyte recruitment and final maturation. This article is general patient education only. Any pre-cycle change to supplementation belongs in conversation with the reproductive endocrinologist managing your cycle.
Is CoQ10 effective for IVF outcomes?
CoQ10 has reasonable randomized data, particularly in women with diminished ovarian reserve, suggesting improved ovarian response and oocyte yield with pre-cycle supplementation over a 60 to 90 day window. Specific doses and forms vary across the literature, and the appropriate choice for any individual patient is a reproductive endocrinology decision.
Can chiropractic care improve IVF success rates?
No. Stenzel Chiropractic Clinic does not market chiropractic adjustment as a fertility treatment. What we offer Mankato-area patients exploring IVF is foundational metabolic and nutritional education to bring to their reproductive endocrinology team, not a substitute for that team's care.
Do I need to stop my IVF medications to do the MitoNAD+ foundational approach?
No. The MitoNAD plus approach is foundational support, not pharmaceutical therapy. It is designed to be discussed with and approved by the reproductive endocrinology team before adoption. Any decision about IVF medications belongs to the reproductive endocrinologist. Do not stop or change any IVF medication based on the contents of this article.
What is the difference between this and standard prenatal vitamins?
Standard prenatal vitamins provide the minimum nutritional support for a planned pregnancy. The MitoNAD plus foundational architecture adds methylation-specific support, mitochondrial cofactor support, and NAD plus precursor support, areas not typically covered by a prenatal multivitamin. Whether any of these additions is appropriate in the pre-cycle window for any individual patient is a reproductive endocrinology decision.
Sources
May-Panloup P, Boucret L, Chao de la Barca JM, et al. Ovarian ageing: the role of mitochondria in oocytes and follicles. Hum Reprod Update. 2016;22(6):725 to 743. PMID 27562289.
Sajic M. Mitochondrial Dynamics in Peripheral Neuropathies. Antioxid Redox Signal. 2014;21(4):601 to 620. PMID 24295466.
Babayev E, Seli E. Oocyte mitochondrial function and reproduction. Curr Opin Obstet Gynecol. 2015;27(3):175 to 181. PMID 25719756.
Gougeon A. Regulation of ovarian follicular development in primates. Endocr Rev. 1996;17(2):121 to 155. PMID 8706629.
Xu Y, Nisenblat V, Lu C, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16:29. PMID 29587861.
Bertoldo MJ, Listijono DR, Ho WJ, et al. NAD+ Repletion Rescues Female Fertility during Reproductive Aging. Cell Rep. 2020;30(6):1670 to 1681. PMID 32049001.
Hammiche F, Vujkovic M, Wijburg W, et al. Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Steril. 2011;95(5):1820 to 1823. PMID 21075376.
Laanpere M, Altmae S, Stavreus-Evers A, Nilsson TK, Yngve A, Salumets A. Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability. Nutr Rev. 2010;68(2):99 to 113. PMID 20137055.
Chu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod. 2018;33(1):65 to 80. PMID 29149263.
Dr. Jordan Stenzel, DC is a Doctor of Chiropractic practicing in Mankato and Mapleton, Minnesota. Stenzel Chiropractic Clinic focuses on foundational metabolic care including the MitoNAD plus approach for mitochondrial and methylation support. This article is general patient education from a chiropractor. It is not medical advice, not infertility care, and not a substitute for evaluation and care by a reproductive endocrinologist. Diagnosis and treatment of infertility require evaluation by a board-certified reproductive endocrinologist. Do not start, stop, or modify any medication, supplementation regimen, or planned reproductive treatment based on this article. Always consult your treating providers first.
Comments